METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON Russian patent published in 2014 - IPC A61K38/21 A61P31/16 

FIELD: biotechnologies.

SUBSTANCE: preparation Reaferonum-EC-lipint is administered sublingually or orally in a single dose of 10000 to 30 IU/kg body weight. An infection is prevented by administering the preparation 30 minutes before meals once a day 2 times a week for 1 month in a dose of 20000 IU/kg in adults and children aged 15 years and older and in a dose of 10000 IU/kg in children between 3 to 15 years old. The infection is treated by administering the preparation 30 minutes before meals two times a day daily for 3-5 days in a dose of 30000 IU/kg in adults and children aged 15 years and older and in a dose of 15000 IU/kg in children between 3 to 15 years old.

EFFECT: prevention and effective treatment of influenza caused by virus subtype H1N1 strains in the patients of various age groups with minimal side effects.

4 cl, 2 tbl, 2 ex